Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
McKesson
AstraZeneca
Medtronic
Johnson and Johnson

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Exela Pharma Scs Llc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for EXELA PHARMA SCS LLC, and when can generic versions of EXELA PHARMA SCS LLC drugs launch?

EXELA PHARMA SCS LLC has ten approved drugs.

There is one US patent protecting EXELA PHARMA SCS LLC drugs.

Summary for Exela Pharma Scs Llc
US Patents:1
Tradenames:10
Ingredients:10
NDAs:10

Drugs and US Patents for Exela Pharma Scs Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Exela Pharma Scs Llc NIPRIDE RTU IN SODIUM CHLORIDE 0.9% sodium nitroprusside SOLUTION;INTRAVENOUS 209387-003 Jul 13, 2018 RX Yes Yes   Start Trial   Start Trial
Exela Pharma Scs Llc NIPRIDE RTU IN SODIUM CHLORIDE 0.9% sodium nitroprusside SOLUTION;INTRAVENOUS 209387-001 Mar 8, 2017 RX Yes Yes   Start Trial   Start Trial
Exela Pharma Scs Llc NIPRIDE RTU IN SODIUM CHLORIDE 0.9% sodium nitroprusside SOLUTION;INTRAVENOUS 209387-002 Dec 7, 2017 DISCN Yes No   Start Trial   Start Trial
Exela Pharma Scs Llc GANCICLOVIR ganciclovir SOLUTION;INTRAVENOUS 209347-001 Feb 17, 2017 RX Yes Yes 9,486,530   Start Trial Y   Start Trial
Exela Pharma Scs Llc POTASSIUM ACETATE potassium acetate INJECTABLE;INJECTION 206203-001 Dec 29, 2015 AP RX No No   Start Trial   Start Trial
Exela Pharma Scs Llc VERAPAMIL HYDROCHLORIDE verapamil hydrochloride SOLUTION;INTRAVENOUS 018925-001 Mar 30, 1984 AP RX No No   Start Trial   Start Trial
Exela Pharma Scs Llc TRANEXAMIC ACID tranexamic acid SOLUTION;INTRAVENOUS 212020-001 Apr 15, 2019 RX Yes Yes   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Dow
Merck
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.